Itron (NASDAQ:ITRI) Stock Price Expected to Rise, Guggenheim Analyst Says

Itron (NASDAQ:ITRI) Stock Price Expected to Rise, Guggenheim Analyst Says

Guggenheim raised their price target on shares of Itron from $133.00 to $155.00 and gave the stock a "buy" rating in a research note on Monday.

Itron, Inc. (NASDAQ:ITRI) Given Average Rating of “Moderate Buy” by Brokerages

Itron, Inc. (NASDAQ:ITRI – Get Free Report) has been given an average rating of “Moderate Buy” by the eleven brokerages that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average twelve-month target price among analysts that have covered the stock in the last year is $128.18. A number of research analysts recently issued report…

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives $16.22 Average PT from Analysts

Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the ten brokerages that are covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year price objective […]

Cisco Systems, Inc. (NASDAQ:CSCO) Receives $69.53 Average Target Price from Analysts

Shares of Cisco Systems, Inc. (NASDAQ:CSCO – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat reports. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a […]